| Funding Opportunity ID: |
293441 |
| Opportunity Number: |
RFA-DA-18-006 |
| Opportunity Title: |
Nasal Delivery of CNS Therapeutics (R43/R44) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Education
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.279 |
| Eligible Applicants: |
Small businesses |
| Additional Information on Eligibility: |
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See Funding Opportunity for eligibility details |
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Apr 25, 2017 |
| Close Date: |
Aug 23, 2017 |
| Last Updated Date: |
Apr 25, 2017 |
| Award Ceiling: |
|
| Award Floor: |
|
| Estimated Total Program Funding: |
|
| Expected Number of Awards: |
|
| Description: |
The purpose of this Small Business Technology Transfer (STTR) RFA is to develop a nasal delivery formulation that reliably delivers of a therapeutic (e.g., peptides, antibodies, RNAi, or pharmacotherapeutics), at a physiologically relevant concentration, into the central nervous system (CNS). |
| Version: |
Synopsis 1 |
